Early recognition of illnesses is essential for improving patient outcomes and reducing the impact of chronic conditions. Traditionally, disease screening has relied on symptomatic observations and invasive diagnostic methods. However, these techniques often fail to identify diseases in their initial stages, when therapy is most effective. Recent a